In the rapidly evolving cannabis industry, there are few platforms for brands to display their products and services in a professional format. Flower Expo, taking place in Massachusetts and Michigan this year, stands out as a beacon of innovation and connection. Flower Expo is the Premier B2B Cannabis Trade Show where brands meet buyers. This unique event is not just a trade show; it’s a movement towards creating a more efficient, high-vibe platform for the cannabis economy.

Flower Expo’s 2024 events, which include Massachusetts on June 5-6 and Michigan on August 7-8, will draw out some of the highest profile names in cannabis. Flower Expo is set to be one of the most important events for top brands and retailers while maintaining the perfect balance of business and culture. 

Flower Expo Massachusetts is set to host more than 150 brands in 2024, including Cresco Labs, PAX, Fernway, Select, Green Thumb Industries, Holistic Industries, Kanha, Nova Farms, and MariMed.

Also set to attend are the purchasing groups from more than 250 Massachusetts retailers, such as Theory Wellness, Rev Clinics, Bud’s Goods & Provisions, Insa, Garden Remedies, and Resinate.

For the Michigan event’s inaugural year, brands such as Bloom, NOBO, Cloud Cover, Glorious Cannabis, Lion Labs, and Pro Gro are set to exhibit, with top retailers Lume Cannabis, High Profile, Joyology, GAGE, Exclusive, and many others set to attend.

Photo Download: https://drive.google.com/file/d/1pOZ1L_-QqlZA85CgcBAFsdeeZFhwFdIR/view?usp=sharing

Jason Bello, founder of the event grew up in Las Vegas, NV, where his father climbed the corporate ladder beginning with the infamous computer trade show COMDEX until its 1996 acquisition, then transitioning to the Las Vegas Sands Corporation, which boasts the largest private convention center in the US, where he opened world renowned hotels in Vegas, Macau, and Singapore. His father was also a founding partner of Hall of Flowers, a California-based cannabis trade show, the event where Bello also got his start in the event business. Following his time at Hall of Flowers, Bello led sales at Source Cannabis and Green Street Festival prior to launching Flower Expo in 2023.

The success of Flower Expo lies in its unique approach to business events. While the show curates the perfect cast of attendees made up of top brands and retail decision makers, its focus on creating an authentic cannabis event with consumption and sampling sets it apart from the field. “What’s a cannabis event without the cannabis?” said Kai Brady, Flower Expo’s Director of Business Development. 

Flower Expo’s fixation on top brands and vetted buyers creates the most ideal sales and marketing opportunity for budding brands to expose purchasing decision makers to their products, packaging, brand values, team members, and culture. “It’s like the biggest farmer’s market you’ve ever been to,” Bello said, “And it’s incredibly important in any industry to procure products with a focus on the consumer — who they are, and what they like.”

After its blockbuster 2023 Massachusetts event, which brought out upwards of 70% of the state’s dispensaries and over 150 of the hottest brands, Flower Expo is set to launch the second iteration of its Massachusetts event on June 5-6, 2024. Additionally, a brand new event is scheduled in Michigan on August 7-8, 2024, set to shake up the Midwestern market. Flower Expo plans to continue its expansion to offer its superior platform to cannabis brands around the country.

About Flower Expo:

At Flower Expo, our mission is to connect and transform the cannabis industry through a professional, high-vibe, and efficient platform. We foster meaningful connections, strategic partnerships, and knowledge exchange to propel the industry forward. With a focus on professionalism, positive energy, and streamlined processes, we empower businesses and individuals to showcase their offerings, inspire innovation, and shape the future of cannabis.

Contact:

ops@theflowerexpo.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Standard Farms Dubbed Best Vape Cartridge in Massachusetts

PHOENIX, March 25, 2024 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today that its subsidiary Standard Farms won first place for best vape cartridge in the 2024 NECANN Cup with the Mimosa Liquid Live Rosin “All-in-One” Vape using the Jupiter/CCELL Voca Pro hardware.

“Being awarded the best vape product at one of the nation’s leading cannabis competitions with our sought-after Mimosa live rosin strain helps solidify TILT’s position as an industry leader in product and hardware innovation,” said Tim Conder, Chief Executive Officer of TILT. “Our team deserves recognition for their commitment to delivering the best cannabis products across the markets we serve.”

Standard Farms’ Voca Pro Liquid Live Rosin “All-In-One” Vape combines the functionality of a high-quality hardware device with the potency and efficacy of a solventless cannabis input material. The Voca Pro device, provided by Jupiter Research and powered by CCELL technologies, is calibrated to ensure the rosin is heated to the perfect temperature for optimal flavor and vapor production, guaranteeing a smooth and flavorful draw from the first inhale to the last.

Massachusetts patients and consumers can find Standard Farms products in-store at any of the Commonwealth Alternative Care, Inc. locations across the state or place an online order for pick-up or delivery at commonwealthaltcare.org.

Dispensaries interested in Standard Farms or any of our other brand partner portfolio products can contact our wholesale team at wholesale@tiltholdings.com.

About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 40 states in the U.S., as well as Canada, Israel, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, and Standard Farms Ohio, LLC in Ohio. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com

Media Contact:
Madison Mullis
Trailblaze
TILT@trailblaze.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

PHOENIX, March 15, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO:TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, has signed an amendment (the “Amendment”) to its previously announced definitive agreement to exercise its purchase option for ownership of its Taunton, Mass. facility (the “Purchase Agreement”). Pursuant to the terms of the Amendment, TILT paid to extend the closing of the transactions contemplated by the Purchase Agreement to a date that is on or before May 31, 2022. The mutually agreed-upon Amendment also extends the due diligence period and the deadline to determine whether TILT will acquire both Unit A and Unit B of the condominium comprising the Taunton facility until May 15, 2022. A copy of the Amendment will be available on the Company’s SEDAR profile at www.sedar.com.

About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 36 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

Instagram: @tiltholdings
Twitter: @TILT_Holdings

Forward-Looking Information

This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, anticipated closing of the Purchase Agreement and estimated timing thereof, potential purchase of both Unit and B or solely Unit A, opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of TILT, and includes statements about, among other things, future developments, operations, expansions and strategy of TILT. Generally, forward looking information can be identified by the use of forward looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to expand its operations and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.

Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of material factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking statements.

For additional information regarding forward-looking statements and their related risks, please refer to the “Risk Factors and Uncertainties” section in the Annual Information Form of the Company for the year ended on December 31, 2020, which is available on the Company’s SEDAR profile at www.sedar.com.

Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
[email protected]

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
[email protected]

720.330.2829

Media Contact:
Juliet Fairbrother
MATTIO Communications
[email protected]

631.338.5343

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

PHOENIX, February 17, 2022 (Globe Newswire) — Tilt Holdings Inc. (“Tilt” or “Company”) (NEO: dance) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technology, cultivation, manufacturing, processing, brand development and retail, today announced a multi-state licensing agreement. ToastAn Aspen, Colorado-born national cannabis brand.

The initial product rollout will begin in Massachusetts through TILT subsidiary Commonwealth Alternative Care, Inc. (“CAC”). Pending regulatory approval, TILT will launch Toast in Pennsylvania and Ohio through its Standard Farm subsidiaries with new SKUs built for each market. TILT will provide full-service wholesale manufacturing, packaging and distribution for many existing Toast SKUs, as well as provide collaborative R&D services to create new products and increase access to high-end cannabis for medical patients and adult-use consumers. Will do

Since its launch in 2017, Toast has differentiated itself through high quality, meticulously crafted products sourced from hemp sourced from leading cultivators in the country. From its USDA Organic Certified tinctures to its vegan, raw chocolate and signature slice pre-rolls, Toast products provide patients and consumers with quality experiences that span the full spectrum of the plant. In the coming months, Toast will introduce a new set of SKUs with TILT that are currently being specially curated for each market.

“Toast is renowned for its impressive craftsmanship and will be a welcome addition to our markets,” said Gary Santo, CEO of TILT Holdings. “Toast is an innovative, high-touch brand, making it a natural fit for TILT’s brand growth strategy as we strive to provide medical patients and adult-consumers a broad range of quality options.”

Puneet Seth, CEO and Co-Founder, Toast, said, “We are committed to increasing access to our quality, life-enhancing products for medical patients and creating moments of celebration for adult-use consumers across the country.” “From the beginning, TILT and Toast have had a shared vision about the best models for scaling brands across multiple states, while staying true to our values ​​and commitment to creating a more equitable industry overall. These three growing markets TILT will be instrumental in bringing toast products to the U.S. at scale, and we are excited to collaborate with their team as they explore additional markets such as New York through their significant partnership with the Shinnecock Indian Nation.

TILT. About this
TILT helps cannabis businesses build brands. Through a portfolio of companies that provide technology, hardware, cultivation and production, TILT services brands and cannabis retailers in 36 states in the US as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly owned subsidiary and a leader in the vaporization segment focused on hardware design, research, development and manufacturing; and Cannabis Operations, Commonwealth Alternative Care, Inc. in Massachusetts. Its partnerships with Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information visit www.tiltholdings.com.

About Toast:
Founded by Bridgewater Associates alumnus Puneet Seth and former Global CMO of Anheuser Bush InBev Chris Berggrave, Toast was born in Aspen, Colorado and became a national cannabis brand. Toasts are meant to celebrate life in the full spectrum – from special moments in life like birthdays and anniversaries to quiet moments in between, there’s always a toast for that. Toast focuses on creating an inclusive and equitable environment within the cannabis industry and selects business partners who share its ethos.

Forbes calls Toast the “Moet Hennessy of Cannabis”. Toast Cannabis products range from specially formulated, micro-dose products designed for the canna-curious, to specially formulated, small-batch products for the discerning cannabis. Toast Flagship Slice Pre-Rolls are crafted to reflect the impact of your favorite beverage. For example, the Toast Original slice is a 2:1 CBD:THC blended pre-roll that reflects the cocktail’s influence, and the Toast Reserve 1:1 CBD:THC blend is similar to Scotch Nite. All Toast products create a unique mind-body experience ideally crafted to celebrate life’s moments. Leam more http://cannabis.wetoast.com, Toast Full Spectrum Hemp products deliver the full power of a cultivated plant with the highest quality standards and are available nationwide http://www.wetoast.com, Follow us on Instagram @WeToast.

forward-looking information
This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans for the future, and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information may include, without limitation, expected initial product rollout through CAC, anticipated receipt of regulatory approval for the launch of Toast in Pennsylvania and Ohio, anticipated scope of services, TILT will provide with respect to Toast products , expected time of launch of new toast SKU, management opinion or beliefs, prospects, opportunities, priorities, goals, targets, ongoing objectives, milestones, strategy and outlook of TILT, and, among other things, future growth Contains statements regarding the operations, expansion and strategy of TILT. In general, forward-looking information can be identified using forward-looking terminology such as “planned”, “expected” or “not expected”, “expected”, “budgeted”, “scheduled”, “estimate”, “forecast”. Is. “intends”, “presumes” or “does not assume”, or “believe”, or variations of such words and phrases or that indicate that certain actions, events or consequences “might”, “might” , “will be”, “may be” or “will be taken”, “will be” or “will be received”. These statements should not be read as a guarantee of future performance or results. These statements are based on certain material factors, assumptions and analyzes that were applied in drawing or forecasting or projection, including TILT’s experience and assumptions of historical trends, its ability to expand its operations, and its expectation of future growth. , as well as other factors that are considered appropriate in the circumstances.

While such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be fulfilled on the conditions described above and that such forward-looking information is the basis for actual results and Will prove to be accurate in future. Events may differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. Unless required by applicable law, TILT undertakes no responsibility to update or revise forward-looking information to reflect new events or circumstances.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of material factors, many of which are beyond TILT’s control, and could cause actual results to differ materially from those discussed in forward-looking statements. are.

For additional information regarding forward-looking statements and their associated risks, please refer to the “Risk factors and uncertainties” section in the Company’s annual information form for the year ended December 31, 2020, available on the Company’s SEDAR profile. Feather www.sedar.com,

dance
Investor Relations Contact:
Shawn Mansoori, CFA
Elevate IR
[email protected]
720.330.2829

media Contact:
Juliet Fairbrother
Matteo Communications
[email protected]
631.338.5343

toast
brook lion mogana
Alison Brod Marketing + Communications
[email protected]
212-230-1800

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Acquisition to Include Two Retail Dispensaries and a Cultivation and Product Manufacturing Facility

Jushi to Enter Its Seventh State and Expand Retail Footprint to 19 Dispensaries Nationwide

BOCA RATON, Fla., April 19, 2021 – Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator announced that it has reached a definitive binding agreement (the “Agreement”) to acquire Nature’s Remedy of Massachusetts, Inc. and certain of its affiliates (collectively, “Nature’s Remedy”), a vertically-integrated single state operator in Massachusetts, for total consideration of up to US$110 million (the “Acquisition”). Nature’s Remedy currently operates two retail dispensaries, in Millbury, MA and Tyngsborough, MA, and a 50,000 sq. ft. cultivation and production facility in Lakeville, MA with approximately 19,500 sq. ft. of high-quality indoor flower canopy and state-of-the-art extraction and manufacturing capabilities (the “Lakeville Facility”).

“We are excited to announce that we have signed a definitive agreement to acquire Nature’s Remedy, a vertically integrated business operating high-quality, well-managed assets in Massachusetts,” said Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi. “Our entrance into Massachusetts will mark the seventh state where we operate cannabis assets and the third state where we are vertically integrated. This acquisition will enable us to rapidly build scale in an important, maturing adult-use market with a defensible retail position and a solid cultivation footprint with significant opportunities to expand. Upon closing, we look forward to working with the current management team to maximize Nature’s Remedy assets, while introducing our own best-in-class brands and high-quality products to the Massachusetts market [watch video here].”

Cultivation and Product Manufacturing Facility of Nature’s Remedy

The 50,000 sq. ft. Lakeville Facility is located within a 185,000 sq. ft. industrial complex. Currently, the Lakeville Facility’s flower canopy encompasses approximately 19,500 sq. ft., which Nature’s Remedy expects to expand to approximately 31,000 sq. ft. during the second half of 2021. The Lakeville Facility utilizes CO₂ extraction and has a full kitchen for edible production. Current flower production at the Lakeville Facility is approximately 6,800 lbs. / year, which, as part of the expected expansion, Nature’s Remedy could increase to approximately 11,000 lbs. / year based on 31,000 sq. ft. of canopy. In addition to the above-mentioned expansion, Nature’s Remedy is evaluating further expansion opportunities in the existing Lakeville industrial complex and/or on ten acres of land owned by Nature’s Remedy in Grafton, MA. The Lakeville Facility could potentially accommodate an additional 18,000 to 20,000 sq. ft. of flower canopy through the expansion into approximately 26,000 sq. ft. of adjacent space in the existing building. In Grafton, MA, Nature’s Remedy has a Host Community Agreement in place with the city and recently received a provisional cultivation license from the Commonwealth. The ten acres of land in Grafton, MA could potentially accommodate a 35,000 to 40,000 sq. ft. new facility with approximately 18,000 sq. ft. of flower canopy. These expansions are subject to business evaluations and needs, and receipt of applicable regulatory approvals.

Millbury Dispensary

The Millbury dispensary is located in the town of Millbury, MA just south of Worcester, MA. The Millbury dispensary caters primarily to the local population and surrounding underserved areas. The Millbury dispensary provides ample parking for its patrons and is strategically situated along the Worcester-Providence Turnpike, which sees approximately 10,600 cars per day. The Millbury dispensary is located in close proximity to the Shoppes at Blackstone Valley, the largest open-air shopping center in Central Massachusetts, and the Mass Turnpike. Upon closing, Jushi will immediately implement its best-in-class, customer-focused retail approach at the Millbury dispensary, which includes its online reservation ordering platform.

Tyngsborough Dispensary

Tyngsborough is located in northern Middlesex county just south of Nashua, New Hampshire. The Tyngsborough dispensary is strategically located in close proximity to the Pheasant Lane Mall, one of the largest malls in New Hampshire, as well as in close proximity to an exit on Route 3 / Northwest Expressway, which sees 60,000 to 80,000 cars per day. There is ample customer parking with potential for expansion. Upon closing, Jushi will immediately implement its best-in-class, customer-focused retail approach at the Tyngsborough dispensary, which includes its online reservation ordering platform.

Agreement Terms

Under the terms of the Agreement, Jushi has agreed to acquire Nature’s Remedy for an upfront payment of US$100 million (subject to purchase price adjustments as set forth in the Agreement), comprised of US$40.0 million in cash, US$55.0 million in subordinate voting shares of the Company (the “Company Shares”)¹ and a US$5.0 million unsecured promissory note.² The Company has also agreed to issue up to an additional US$10.0 million in Company Shares upon the occurrence or non-occurrence of certain conditions after the closing date (the “Additional Consideration”), bringing the total potential consideration for the Acquisition paid by the Company to US$110 million. The purchase price (inclusive of the full US$10.0 million of Additional Consideration) is expected to represent a multiple of approximately 4.5 to 5.0x Nature’s Remedy’s full year 2021 EBITDA³ and approximately 2.9 to 3.2x Nature’s Remedy’s full year 2022 EBITDA.³

The Acquisition, which is expected to close in the second half of 2021, is subject to certain customary closing conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act and approvals from other applicable regulatory authorities. Pursuant to the terms of the Agreement, the Company has the right to terminate the Agreement within 30 days of execution if the Company is not satisfied with its due diligence of Nature’s Remedy for any reason. In addition, the Company has the right to terminate the Agreement if the average of the daily volume weighted average price for a Company Share for the fifteen (15) trading days immediately preceding the closing date (the “Closing Share Price”) would be equal to or less than eighty percent (80%) of the average of the daily volume weighted average price for a Company Share for the fifteen (15) trading days immediately preceding the Agreement’s execution date (the “Execution Share Price”) and Nature’s Remedy has the right to terminate the Agreement if the Closing Share Price would be equal to or less than sixty percent (60%) of the Execution Share Price. There can be no assurance that the Acquisition will be completed.

¹ Price per share calculation is equal to the average of the daily volume weighted average price for Company Share (in United States Dollars) on the fifteen (15) trading days immediately preceding the closing date, and which shall not be less than eighty-five percent (85%) of the closing price for a Company Share (in United States Dollars) on the trading day immediately preceding the closing date.

² The promissory note provides for cash interest payments to be made quarterly, a five-year maturity and all principal and accrued and unpaid interest due at maturity.

³ See “Reconciliation of Non-IFRS Financial Measures” at the end of this press release for more information regarding the Company’s use of non-IFRS financial measures.

About Jushi Holdings Inc.

We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, please visit jushico.com or our social media channels, Instagram, Facebook, Twitter, and LinkedIn.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, involve estimates, projections, plans, goals, forecasts, and assumptions that may prove to be inaccurate. As a result, actual results could differ materially from those expressed by such forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or may contain statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “will continue,” “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has certain expectations and has made certain assumptions. Expectations, assumptions, and risk factors are more fully described in the Company’s Management, Discussion and Analysis for the three months ended September 30, 2020, and other filings with securities and regulatory authorities which are available at www.sedar.com.  Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Actual results could differ materially from those expressed by such forward-looking statements, and such statements should not be relied upon. Key expectations and assumptions made by Jushi include, but are not limited to, the accuracy of the books and records, and business models of Nature’s Remedy as provided in due diligence; the continued performance of existing operations of Nature’s Remedy; the anticipated expansion of Nature’s Remedy expected by the end of the second quarter of 2021; the expansion and optimization of the Lakeville Facility, adjacent buildings and property in Grafton, MA; and licensing approval. Additional risk factors that may affect actual results are detailed in Jushi’s annual information form and other periodic filings. These documents may be accessed via SEDAR database.

Not for distribution to United States newswire services or for dissemination in the United States.

For further information, please contact:

Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-281-0247
[email protected]

Media Contact:
Ellen Mellody
MATTIO Communications
570-209-2947
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.